PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $50,000 | -3.8% | 13,124 | +29.0% | 0.00% | – |
Q4 2019 | $52,000 | -1.9% | 10,171 | -3.9% | 0.00% | – |
Q3 2019 | $53,000 | -26.4% | 10,579 | -9.0% | 0.00% | – |
Q2 2019 | $72,000 | +28.6% | 11,627 | -3.9% | 0.00% | – |
Q1 2019 | $56,000 | +21.7% | 12,100 | +11.3% | 0.00% | – |
Q4 2018 | $46,000 | -38.7% | 10,872 | -9.6% | 0.00% | – |
Q3 2018 | $75,000 | -29.9% | 12,023 | -9.9% | 0.00% | – |
Q2 2018 | $107,000 | +7.0% | 13,345 | -0.8% | 0.00% | – |
Q1 2018 | $100,000 | +51.5% | 13,456 | +21.9% | 0.00% | – |
Q4 2017 | $66,000 | -18.5% | 11,041 | +0.5% | 0.00% | – |
Q3 2017 | $81,000 | -39.1% | 10,989 | -25.2% | 0.00% | -100.0% |
Q1 2017 | $133,000 | +2.3% | 14,693 | -2.4% | 0.00% | 0.0% |
Q4 2016 | $130,000 | – | 15,051 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|